arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Edgewise Therapeutics, Inc.

EWTX

$41.05 ▼ -3.43 (-7.72%) at close

27 Visible periods

21 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Edgewise Therapeutics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $4.4B

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -10.9% ↘

FCF / Share $-0.39 →

Trailing P/E —

Price / Book 9.9x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

27-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-49.01M

↓ -20.1% —

FCF / Share Free cash flow per share

$-0.39

↑ +1.2% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗
EPS Growth YoY (%)	-55.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-7.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-14.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-8.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	-30.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	10.6% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	12.2% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	8.3% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-56.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-20.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-6.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-20.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-25.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-30.8% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-52.4% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-20.1% Weak ↑ Weak Improving Year-over-year change in net income	-20.1% Weak ↑ Weak Improving Year-over-year change in net income	-26.6% Weak ↑ Weak Improving Year-over-year change in net income	-43.0% Weak ↓ Weak Declining Year-over-year change in net income	-43.0% Weak ↓ Weak Declining Year-over-year change in net income	-43.0% Weak ↓ Weak Declining Year-over-year change in net income	-31.6% Weak ↓ Weak Declining Year-over-year change in net income	-24.9% Weak ↑ Weak Improving Year-over-year change in net income	-24.9% Weak ↑ Weak Improving Year-over-year change in net income	-24.9% Weak ↑ Weak Improving Year-over-year change in net income	-55.3% Weak → Weak Stable Year-over-year change in net income	-55.8% Weak → Weak Stable Year-over-year change in net income	-55.8% Weak ↑ Weak Improving Year-over-year change in net income	-55.8% Weak ↑ Weak Improving Year-over-year change in net income	-52.9% Weak ↑ Weak Improving Year-over-year change in net income	-115.1% Weak → Weak Stable Year-over-year change in net income	-115.1% Weak → Weak Stable Year-over-year change in net income	-115.1% Weak ↓ Weak Declining Year-over-year change in net income	-100.2% Weak ↑ Weak Improving Year-over-year change in net income	-114.0% Weak → Weak Stable Year-over-year change in net income	-114.0% Weak Weak Year-over-year change in net income	-114.0% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	—	-0.4% Weak Weak Year-over-year change in free cash flow	—	—	—	-20.6% Weak Weak Year-over-year change in free cash flow	—	—	—	23.2% Good Good Year-over-year change in free cash flow	—	—	—	-64.6% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗
FCF / Net Income (x)	0.87x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.93x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.01x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.19x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.88x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.28x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.44x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.03x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	1.31x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗
Return on Invested Capital (%)	-10.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.5% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-5.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-1.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	15.0% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	10.6% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	13.2% Good Good Return earned on debt + equity capital invested Optimal: > 10%	12.8% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-12.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-9.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	-4.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-2.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-4.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-10.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-173%)	-9.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-166%)	-9.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-164%)	-7.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-149%)	-6.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-146%)	-9.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-163%)	-8.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-158%)	-5.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-139%)	-5.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-137%)	-5.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-136%)	-9.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-163%)	-7.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-152%)	-7.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-149%)	-6.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-146%)	-5.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-137%)	-4.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-127%)	-6.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-140%)	-5.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-138%)	-4.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-131%)	-2.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-116%)	-2.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-115%)	-2.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-115%)	19.0% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+27%)	11.7% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-22%)	13.4% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-11%)	15.9% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+6%)	—

⚖️ Is the balance sheet risky? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗
Debt to Equity (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-72.32M	$-33.21M	$-61.15M	$-46.00M	$-43.40M	$-49.92M	$-41.67M	$-44.81M	$-43.48M	$-30.26M	—	$-32.96M	$-31.81M	$-48.23M	$-21.99M	$-109.68M	$-18.34M	$-34.45M	$-15.57M	—	—	$-221.04M	$-104.92M	$-38.73M	$-16.87M	$-20.91M	$-23.65M
Debt / EBITDA (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗
Basic EPS, GAAP (USD)	$-0.53	$-0.46	$-0.48	$-0.39	$-0.34	$-0.43	$-0.42	$-0.36	$-0.34	$-0.33	$-0.47	$-0.41	$-0.34	$-0.36	$-0.30	$-0.34	$-0.32	$-0.30	$-0.24	$-0.26	$-0.21	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.39	$-0.40	—	$-0.33	—	$-0.40	—	—	—	$-0.33	—	—	—	$-0.43	—	—	—	$-0.26	—	$-0.18	$-0.20	—	—	—	—	—	—
Book Value per Share (USD)	$4.16	$4.59	$4.92	$5.28	$5.59	$4.51	$4.84	$5.18	$5.45	$5.73	—	$4.58	$4.91	$5.20	$5.48	$5.72	$4.95	$5.25	$5.54	$5.79	$6.02	$6.22	$-33.11	—	—	—	—
Tangible Book Value per Share (USD)	$4.16	$4.59	$4.92	$5.28	$5.59	$4.51	$4.84	$5.18	$5.45	$5.73	—	$4.58	$4.91	$5.20	$5.48	$5.72	$4.95	$5.25	$5.54	$5.79	$6.02	$6.22	$-33.11	—	—	—	—
Basic Weighted Avg Shares (shares)	107.67M	107.12M	—	105.49M	104.94M	95.13M	—	93.81M	93.52M	87.57M	—	63.46M	63.38M	63.27M	—	51.84M	49.62M	49.54M	—	49.26M	49.26M	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗
Working Capital (USD)	$442.48M	$487.25M	$516.01M	$552.25M	$582.36M	$422.06M	$451.62M	$480.48M	$502.26M	$526.83M	—	$281.58M	$302.60M	$320.65M	$340.41M	$356.84M	$244.13M	$258.61M	$273.25M	—	—	$305.69M	$125.30M	—	—	—	—
LT Debt (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$59.00K	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$448.08M	$493.20M	$522.26M	$558.65M	$589.07M	$429.72M	$459.22M	$488.88M	$510.47M	$534.94M	$318.83M	$290.43M	$311.45M	$328.84M	$346.72M	$361.40M	$246.35M	$260.36M	$274.38M	$285.40M	$296.75M	$306.39M	$-33.42M	$-27.27M	$-23.76M	$-19.98M	$-16.85M

📋 What is driving earnings? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗
Depreciation Expense (USD)	$500.00K	$537.00K	$525.00K	$500.00K	$500.00K	$513.00K	$577.00K	$500.00K	$500.00K	$473.00K	$483.00K	$400.00K	$400.00K	$195.00K	$88.00K	$100.00K	$97.00K	$83.00K	$78.00K	$100.00K	$51.00K	$79.00K	$50.00K	$49.00K	$46.00K	$40.00K	—
Net Income, GAAP (USD)	$-49.01M	$-49.01M	$-50.22M	$-40.80M	$-40.80M	$-40.80M	$-39.66M	$-28.52M	$-28.52M	$-28.52M	$-30.14M	$-22.84M	$-22.84M	$-22.84M	$-19.41M	$-14.66M	$-14.66M	$-14.66M	$-12.70M	$-6.82M	$-6.82M	$-6.82M	$-6.34M	$-3.19M	$-3.19M	$-3.19M	—
Operating Cash Flow (USD)	$-42.47M	$-42.54M	$-38.59M	$-34.78M	—	$-37.87M	$-26.96M	—	—	$-28.60M	$-26.83M	—	—	$-22.83M	$-11.86M	—	—	$-12.57M	$-9.42M	$-8.26M	$-9.77M	$-6.06M	$-4.64M	$-3.27M	$-3.98M	$-2.74M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 2 days ago 7 years · 27 quarters

Edgewise Therapeutics, Inc.

Analytical Summary

27-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare EWTX with peers